MedTrace Logo

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

NCT02302859 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-01-27

Study results available
· View outcomes & findings →

Summary

The goal of this research study is to learn about 2 different interactive methods that are designed to help people with HIV/AIDS stop smoking.

Conditions

  • Tobacco Use Cessation

Interventions

DRUG

Nicotine Patch

Participants receive an 8 week supply of Nicotine patches.

BEHAVIORAL

Questionnaires

Questionnaire completion at baseline on laptop, then weekly for 8 weeks on smartphone, then 3 months after smartphone intervention.

OTHER

Pamphlet

Pamphlet given to participant describing health and financial reasons to quit smoking.

BEHAVIORAL

Phone Counseling Sessions

Standard Treatment (ST) Group: Participants receive 8 phone counseling sessions (one session per week) for support in quitting smoking. The calls should last about 15 minutes. Automated Treatment (AT) Group: Participants receive brief video clips with advice on how to quit smoking over smartphone, as well as interactive text and picture messages once a week for 8 weeks. The video clips will be about 5 minutes long. Participants also have access to additional counseling content on the smart phone, which can be used at any time.

OTHER

Saliva Test

Participants complete saliva cotinine test 3 months after intervention.

DEVICE

Smart phone

Standard Treatment (ST) Group: Participants receive proactive phone counseling (8 sessions) over the 8-week period for support in quitting smoking. The call will last about 15 minutes. Automated Treatment (AT) Group: Participants receive brief advice to quit smoking (tailored video clips) and an 8-week automated intervention (interactive text messages and graphical messages) for support in quitting smoking via smartphone.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Diana S. Hoover, PHD · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02302859 on ClinicalTrials.gov